Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018

SELL
$20.16 - $24.68 $4.81 Million - $5.88 Million
-238,400 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$20.31 - $24.95 $773,100 - $949,721
38,065 Added 19.0%
238,400 $5.05 Million
Q4 2017

Feb 14, 2018

BUY
$20.99 - $23.89 $883,825 - $1.01 Million
42,107 Added 26.61%
200,335 $4.59 Million
Q3 2017

Nov 13, 2017

BUY
$20.07 - $21.89 $3.18 Million - $3.46 Million
158,228
158,228 $3.46 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.33B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track William Blair Investment Management, LLC Portfolio

Follow William Blair Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of William Blair Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on William Blair Investment Management, LLC with notifications on news.